Vertex Pharmaceuticals

VRTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$510.21

+$1.87 (+0.37%)

Sep 21, 2026, 11:54 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	12.07B	11.02B	9.87B	8.93B	7.57B	6.21B
Cost of Revenue	1.81B	1.53B	1.26B	1.08B	904.2M	736.3M
Gross Profit	10.27B	9.49B	8.61B	7.85B	6.67B	5.47B
Operating Income	4.76B	-232.9M	3.83B	4.31B	2.78B	2.86B
Interest Income	490.9M	598.1M	614.7M	144.6M	4.9M	22.2M
Pretax Income	4.64B	248.5M	4.38B	4.23B	2.73B	3.12B
Net Income	3.95B	-535.6M	3.62B	3.32B	2.34B	2.71B
Selling & General & Admin	1.75B	1.46B	1.14B	944.7M	840.1M	770.5M
Research & Development	3.75B	3.63B	3.16B	2.66B	3.05B	1.83B
Other Expenses	n/a	4.63B	475.5M	-57.5M	n/a	13.06M
Operating Expenses	5.51B	9.72B	4.78B	3.54B	3.89B	2.61B
Interest Expense	13.3M	30.6M	44.1M	54.8M	61.5M	58.15M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	7.31B	11.25B	6.04B	4.62B	4.79B	3.35B
Income Tax Expense	690M	784.1M	760.2M	910.4M	388.3M	405.15M
Shares Outstanding (Basic)	255.7M	257.5M	257.7M	256.1M	257.7M	259.84M
Shares Outstanding (Diluted)	258M	257.9M	260.5M	259.1M	259.9M	263.4M
EPS (Basic)	15.46	-2.08	14.05	12.97	9.09	10.44
EPS (Diluted)	15.32	-2.08	13.89	12.82	9.01	10.29
EBITDA	4.86B	486.3M	4.61B	4.44B	2.92B	3.28B
EBIT	4.66B	279.1M	4.42B	4.29B	2.79B	3.17B
Depreciation & Amortization	207.2M	205.8M	181.3M	148.3M	125.6M	109.52M